CAS: 1844849-10-0
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | PF 06821497 REF: 3D-UYC84910CAS: 1844849-10-0 | Min. 95% | Nachfragen | Mo 14 Apr 25 |
 | PF-06821497 REF: TM-T12430CAS: 1844849-10-0 | 97.88% | 96,00 €~938,00 € | Mo 16 Jun 25 |
PF 06821497
CAS:1844849-10-0
PF 06821497 is a potential drug for the treatment of Creutzfeldt-Jakob disease (CJD). It is …
Formel:
C22H24Cl2N2O5
Reinheit:
Min. 95%
Molekulargewicht:
467.3 g/mol
Ref: 3D-UYC84910
| 5mg | 1.039,00 € | ||
| 10mg | 1.361,00 € | ||
| 25mg | 2.551,00 € | ||
| 50mg | 4.082,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 14. April 2025
PF-06821497
CAS:1844849-10-0
PF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhibition.Cost-effective and quality-assured.
Formel:
C22H24Cl2N2O5
Reinheit:
97.88%
Farbe und Form:
Solid
Molekulargewicht:
467.34
Ref: TM-T12430
| 1mg | 96,00 € | ||
| 5mg | 227,00 € | ||
| 10mg | 354,00 € | ||
| 25mg | 533,00 € | ||
| 50mg | 747,00 € | ||
| 100mg | 938,00 € | ||
| 1mL*10mM (DMSO) | 208,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 16. Juni 2025
